ERCC1 and lung cancer: To confirm that compound 6 was able to disrupt the interaction between subunits in the ERCC1-XPF heterodimer in cells, we performed PLA using A549 lung cancer cells exposed to 2 μM compound 6 or DMSO vehicle for 24 h.